TreeFrog Therapeutics I iPS-derived cell therapies https://validator.w3.org/feed/docs/rss2.html 10 International Scientists Nominated For The $100,000 Stem Cell SpaceShot Grant Disclaimer Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors Our blog “In the Stem Cell Jungle” is out About us TreeFrog celebrates its third birthday, announcing a two-fold increase in lab capacity ! Credits New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo Happy 2022 from the Froggies (showcasing our egg/chicken/dino dance moves) ! Past Events Events TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies TreeFrog Therapeutics moves to GMP manufacturing with cell encapsulation device delivered by Invetech Exponential hiPSC expansion in 10L bioreactors with C-Stem™ published in Biomaterials TreeFrog Therapeutics appoints Scientific Advisory Board to guide the development of proprietary iPS platform & cell therapy pipeline TreeFrog Therapeutics back in the FrenchTech120 Stem Cell SpaceShot Grant – Contest Rules TreeFrog Therapeutics launches a $100,000 research grant in regenerative medicine Cell therapy pipeline Stem cell spaceshot grant Careers 2023 TreeFrog’s wishes 3 PhD students from King’s College London win the $100,000 Stem Cell SpaceShot grant TreeFrog Therapeutics expands Board with new independent members from the cell therapy industry Publications Applications for the Stem Cell SpaceShot Grant Now Open! Privacy Statement (EU) Peter Nell joins TreeFrog Therapeutics as Independent Board Member C-Stem™ technology News Interview: Teisha Rowland, Ph.D., Principal Scientist, Umoja Biopharma Media Impressum Privacy Statement (ZA) Imprint Privacy Statement (AU) Cookie Policy (ZA) Privacy Statement (US) Cookie Policy (CA) Privacy Statement (CA) Cookie Policy (AU) Cookie Policy (UK) Privacy Statement (UK) Cookie Policy (US) Cookie Policy (EU) Home Contact Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology Test formulaire salesforce 2 EIC ScalingUp TOP50: TreeFrog Therapeutics selected among 3,000 European Deeptech companies